Romiplostim (Nplate®)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-0597b532014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
10 Sept 2025
Other contracts from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| Information Technology Service Management | contract | — | 08 May 2026 |
| Patient Carer Online Feedback Service | contract | — | 08 May 2026 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 30 Mar 2026 |
| NP884925 Adobe Licence | contract | — | 27 Mar 2026 |
| Automated AST & Bacteria Testing | contract | — | 27 Mar 2026 |
| Sampling & Measuring Products | contract | — | 25 Mar 2026 |
| NP90726l Tildrakizumab (Ilumetri®) | contract | — | 17 Mar 2026 |
| Ophthalmology Equipment | contract | £8.0m | 11 Mar 2026 |
| Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables | contract | £100.0m | 11 Mar 2026 |
| Single Use Podiatry Instruments | contract | £2.0m | 11 Mar 2026 |
Other contracts awarded to Amgen Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Transitional Drugs 6 | contract | — | 30 Mar 2026 |
| Transitional Drugs 6 | contract | — | 04 Feb 2026 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 19 Dec 2025 |
| NHS National Framework for Denosumab Injection commencing 1st January 2026 | contract | — | 04 Dec 2025 |
| Project/Contract NHS National Framework for Denosumab Injection | contract | — | 02 Oct 2025 |
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | contract | £47.0m | 29 Jul 2025 |
| NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 | contract | — | 29 Jul 2025 |
| NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | contract | £9.4m | 24 Jul 2025 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | contract | — | 24 Jul 2025 |
| Biologic and Biosimilar Medicines | contract | — | 21 May 2025 |